This case study aims to provide a better understanding of the necessity for regulation in the market for … pharmaceuticals and to reveal the impacts of parallel trades in the European Union and how they may affect markets in the future. The … pharmaceuticals. Consequently, the price gap and other EU-specific factors have created a great environment for parallel trades. The …

position of the US as a locus of innovation in pharmaceuticals has increased over the past decade compared to Europe. All in … European countries. As a whole, Europe is lagging behind in its ability to generate, organise, and sustain innovation processes … in pharmaceuticals: 1) The size and the structure of the biomedical education and research systems; 2) Some basic …

chapter in conjunction with Chapter 19, which deals with knowledge, information and innovation. In this chapter, we are …

We look at the effect of the US Sarbanes-Oxley (SOX) financial regulation on industrial innovation. Our theoretical …

potential determinants of innovation; and (ii) analysing the effects of governance and regulation on innovation in conjunction … Greenwich in September 2011 and will be published as an edited book titled Governance, Regulation and Innovation: Theory and …We introduce new studies that argue in favour of: (i) according a central role to governance and regulation as …

answer this question, the paper focuses on the problem of investment and innovation in an ex ante regulated sector. Relying … on existing literature, we argue that ex ante regulation could represent a danger for the long-term development of the … infrastructures. We also argue that ex ante regulation is distorting investment itself: incremental investment is privileged as …